Mira Pharmaceuticals Inc (MIRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,642 | 731 | 1,206 | 2,833 | 4,145 |
| Marketable Securities | 4,894 | N/A | N/A | N/A | N/A |
| TOTAL | $7,598 | $833 | $1,365 | $2,888 | $4,231 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 35 | 35 | 35 | 35 | 35 |
| TOTAL | $35 | $35 | $35 | $35 | $35 |
| Total Assets | $7,633 | $868 | $1,400 | $2,923 | $4,267 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 84 | 299 | 101 | 423 | 693 |
| Accrued Expenses | 0 | 0 | 6 | 300 | N/A |
| TOTAL | $84 | $299 | $106 | $723 | $693 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $84 | $299 | $106 | $723 | $693 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 41,876 | 19,069 | 16,920 | 16,814 | 16,561 |
| Common Shares | 4 | 2 | 2 | 2 | 2 |
| Retained earnings | -33,597 | -32,459 | -30,922 | -29,138 | -26,738 |
| TOTAL | $7,549 | $570 | $1,294 | $2,200 | $3,574 |
| Total Liabilities And Equity | $7,633 | $868 | $1,400 | $2,923 | $4,267 |